Melatonin + B6 Lozenges

Produit de santé naturel homologué au Canada

Titulaire: Biomed International Products Corp.
NPN ou DIN-HM: 80066072
Statut: Licence active
Date de licence: 22 décembre 2015
Date de révision: Non renseignée
Forme: Pastille
Voie d'administration: Buccale
Type de demande: Non traditionnelle

L’analyse des doses orales ne s’applique pas sans voie exclusivement orale établie.

Composition

Ingrédient médicinal et source	Par unité posologique, selon la source
N-acétyl-5-méthoxytryptamine Source : Mélatonine	10 mg
Vitamine B6 Source : Vitamine B6	10 mg

Ingrédients non médicinaux

Stéarate de magnésium, Cellulose microcristalline, Saveur, Acide citrique, Phosphate de calcium, dibasique, anhydre, Crospovidone, Xylitol, Feuille de Stevia rebaudiana, D-Mannitol

Doses recommandées au Canada

Population	Âge	Quantité par prise	Fréquence
Adultes	minimum : 19 ans	1 Pastille	1 Tous les jours

Usages autorisés au Canada

Texte fourni en anglais, faute de texte français disponible.

Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps to prevent and/or reduce the effects of jet lag (e.g. daytime fatigue, sleep disturbance) for people travelling by plane easterly across two or more time zones. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. Helps re-set the body's sleep-week cycle (aspect of the circadian rhythm).

Un usage autorisé au Canada n'est pas une allégation de santé autorisée dans l'Union européenne. Consultez le registre des allégations de santé.

Mises en garde au Canada

Précautions et mises en garde
Consumption with alcohol, other medications or natural health products with sedative properties is not recommended. If you are taking one of the following medications, consult a health care practitioner prior use: anticoagulant, anticonvulsant, blood pressure medications, immunosuppressive medications, sedative, hypnotic or psychotropic. If you have one of the following conditions, consult a health care practitioner prior to use: asthma, cardiovascular disease, chronic kidney disease, depression, diabetes or hypoglycaemia, hormonal disorder, immune system disease, liver disease, migraine, or seizure disorders. If symptoms persist continuously for more than 4 weeks (chronic insomnia), consult your health care practitioner.
Contre-indications
If you are pregnant or breastfeeding, do not use this product.
Effets indésirables connus
Mild gastrointestinal symptoms (nausea, vomiting, or cramping) have been known to occur in which case. Rare allergic reactions have been known to occur in which case, discontinue use.